How the Body's Endocannabinoid System Drives Appetite, Food Motivation, and Weight Regulation | Research

The takeaway

Research confirms endocannabinoids acting at brain CB1 receptors stimulate appetite by enhancing food motivation and taste pleasure, with cannabinoid receptor blockers showing potential as anti-obesity treatments.

Read this if you want to understand the science behind why cannabis increases appetite and how that knowledge could lead to new weight management treatments.

Endocannabinoids increase appetite through two routes: making food more attractive and making food taste better

What the researchers found

This review compiled evidence on the endocannabinoid system's role in appetite and body weight regulation. Endocannabinoids acting at CB1 cannabinoid receptors in the brain stimulate appetite and eating behaviors, partly through interactions with established hunger and satiety signals.

Key brain structures sensitive to endocannabinoid appetite stimulation include the nucleus accumbens and hypothalamic nuclei. Endocannabinoid activity in these regions varies with nutritional status and feeding behavior.

Behavioral studies revealed endocannabinoids increase eating motivation through two mechanisms: enhancing the incentive salience of food (making food more attractive) and enhancing hedonic evaluation (making food taste better). Beyond appetite, endocannabinoids also play a role in energy metabolism and fuel storage. CB1 receptor antagonists showed potential clinical benefits for managing obesity.

Why it matters

Understanding exactly how the endocannabinoid system drives appetite explains the well-known "munchies" phenomenon at a neurobiological level. More importantly, it identified endocannabinoid receptors as a viable drug target for both increasing appetite (in wasting conditions) and decreasing it (in obesity).

The numbers in context

CB1 receptors identified as the key receptor for appetite stimulation. Key brain regions: nucleus accumbens and hypothalamic nuclei. Two mechanisms: incentive salience (food wanting) and hedonic evaluation (food liking). Endocannabinoid activity varies with nutritional status.

How the study worked

Narrative review compiling evidence from animal behavioral studies, receptor pharmacology, brain imaging, and clinical trials on the role of endocannabinoids in appetite, eating behavior, and body weight regulation.

What this study cannot tell us

Much of the evidence comes from animal studies. The complexity of appetite regulation means endocannabinoid effects interact with many other signaling systems. Clinical translation of CB1 antagonists later encountered problems with psychiatric side effects.

How to read the evidence

Comprehensive narrative review synthesizing animal behavioral, pharmacological, and emerging clinical evidence. Strong mechanistic evidence but clinical applications were still developing.

When this study was published

Published in 2005. The CB1 antagonist rimonabant was later approved for obesity in Europe but withdrawn due to psychiatric side effects. Research into safer endocannabinoid-based appetite modulators continues.

The bigger picture

The dual role of endocannabinoids in both appetite stimulation and energy metabolism helps explain why cannabis users often experience increased appetite. It also opened a therapeutic avenue: CB1 antagonists for obesity and CB1 agonists for conditions involving appetite loss, like cancer cachexia or anorexia.

Questions still open

Can endocannabinoid-based appetite treatments be developed without psychiatric side effects? How do chronic cannabis users adapt to the appetite-stimulating effects over time?

Common questions

Why does cannabis make you hungry?

THC activates CB1 cannabinoid receptors in brain areas that control appetite, particularly the nucleus accumbens and hypothalamus. This increases both the motivation to seek food (making food seem more attractive) and the pleasure of eating (making food taste better).

Could blocking cannabinoid receptors help with weight loss?

The research reviewed here suggested CB1 receptor antagonists could reduce appetite and food intake. The drug rimonabant was developed based on this principle but was later withdrawn due to side effects. Safer approaches are being investigated.

Read the original research

Endocannabinoids in the regulation of appetite and body weight.

Behavioural pharmacology, 16(5-6), 297-313

View on PubMed ↗

Citation

Kirkham, T C. (2005). Endocannabinoids in the regulation of appetite and body weight.. Behavioural pharmacology, 16(5-6), 297-313.